Understanding CKD Diagnosis and Treatment in Heart Disease Patients
The Diagnosis and Treatment Pattern of CKD in Patients With Cardiovascular Disease- a National Cross-sectional Study
This study is trying to learn more about how chronic kidney disease is diagnosed and treated in heart disease patients by collecting information from around 2000 people in China.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Guangdong Provincial People's Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06143995 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data from approximately 2000 patients with cardiovascular disease who have evidence of chronic kidney disease (CKD). Participants will be recruited from around 25 sites in China and will undergo a baseline visit where their demographics, lifestyle factors, clinical characteristics, and laboratory tests will be collected. The study focuses on estimating the diagnosis rate of CKD, assessing awareness and treatment patterns, and describing the socio-demographic and clinical characteristics of these patients. The findings will help improve understanding of CKD in the context of cardiovascular disease.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with cardiovascular disease and laboratory evidence of chronic kidney disease.
Not a fit: Patients with severe kidney impairment (eGFR <20 ml/min/1.73 m2), those on dialysis or kidney transplant, and pregnant or lactating women may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and management of chronic kidney disease in patients with cardiovascular conditions.
How similar studies have performed: Other studies have shown success in understanding the interplay between chronic kidney disease and cardiovascular disease, making this approach relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Female and/or male aged ≥18 years 2. Admitted to the cardiology department with diagnosed cardiovascular disease within the previous 12 months 3. Participants with eGFR\<60 ml/min/1.73 m2 and/or UACR\>30 mg/g at least twice 3 months apart within the previous 12 months Exclusion Criteria: 1. Participants with known eGFR\<20 ml/min/1.73 m2 or undergoing dialysis or kidney transplantation 2. Pregnant or lactating women 3. Exposure to contrast medium or other reason leading to potential acute kidney injury since the baseline examination of eGFR/UACR 4. Patients who were participating in or had participated in any other clinical trial within the previous 12 months
Where this trial is running
Guangzhou, Guangdong
- Guangdong Provincial People's Hospital — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Chen Jiyan, PHD
- Email: Chen-jiyan@163.com
- Phone: 86-020-83827812-10528
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.